Advertisement

Journal of Nuclear Cardiology

, Volume 25, Issue 2, pp 685–687 | Cite as

Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI

  • Takatoyo Kiko
  • Atsuro Masuda
  • Ayaka Nemoto
  • Hideyuki Tominaga
  • Noboru Oriuchi
  • Akiomi Yoshihisa
  • Yasuchika Takeishi
Images that Teach

Notes

Disclosure

None

References

  1. 1.
    Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: Comparison to CR using integrated PET/MRI. J Nucl Cardiol. 2016. doi: 10.1007/s12350016-0616-y.Google Scholar
  2. 2.
    Wada K, Niitsuma T, Yamaki T, Masuda A, Ito H, Kubo H, et al. Simultaneous cardiac imaging to detect inflammation and scar tissue with 18F-fluorodeoxyglucose in cardiac sarcoidosis. J Nucl Cardiol. 2016;23:1180–2.CrossRefPubMedGoogle Scholar
  3. 3.
    Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;17:1683–90.CrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2017

Authors and Affiliations

  • Takatoyo Kiko
    • 1
  • Atsuro Masuda
    • 1
  • Ayaka Nemoto
    • 2
  • Hideyuki Tominaga
    • 2
  • Noboru Oriuchi
    • 2
  • Akiomi Yoshihisa
    • 1
  • Yasuchika Takeishi
    • 1
  1. 1.Department of Cardiovascular MedicineFukushima Medical UniversityFukushimaJapan
  2. 2.Advanced Clinical Research CenterFukushima Medical UniversityFukushimaJapan

Personalised recommendations